| Angiopoietins in angiogenesis E Fagiani, G Christofori Cancer letters 328 (1), 18-26, 2013 | 812 | 2013 |
| Targeting metabolic symbiosis to overcome resistance to anti-angiogenic therapy L Pisarsky, R Bill, E Fagiani, S Dimeloe, RW Goosen, J Hagmann, C Hess, ... Cell reports 15 (6), 1161-1174, 2016 | 216 | 2016 |
| Angiopoietin-1 and-2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis E Fagiani, P Lorentz, L Kopfstein, G Christofori Cancer research 71 (17), 5717-5727, 2011 | 134 | 2011 |
| RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas E Fagiani, G Giardina, L Luzi, M Cesaroni, M Quarto, M Capra, ... Cancer research 67 (7), 3064-3073, 2007 | 87 | 2007 |
| The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer S Tiede, N Meyer-Schaller, RKR Kalathur, R Ivanek, E Fagiani, ... Oncogenesis 7 (9), 73, 2018 | 72 | 2018 |
| Proangiogenic Factor PlGF Programs CD11b+ Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic Progenitors J Laurent, EF Hull, C Touvrey, F Kuonen, Q Lan, G Lorusso, MA Doucey, ... Cancer research 71 (11), 3781-3791, 2011 | 43 | 2011 |
| Nintedanib is a highly effective therapeutic for neuroendocrine carcinoma of the pancreas (PNET) in the Rip1Tag2 transgenic mouse model R Bill, E Fagiani, A Zumsteg, H Antoniadis, D Johansson, S Haefliger, ... Clinical cancer research 21 (21), 4856-4867, 2015 | 35 | 2015 |
| Characterization of a Schwann cell enhancer in the myelin basic protein gene C Taveggia, A Pizzagalli, E Fagiani, A Messing, ML Feltri, L Wrabetz Journal of neurochemistry 91 (4), 813-824, 2004 | 18 | 2004 |
| Junctional adhesion molecule B interferes with angiogenic VEGF/VEGFR2 signaling M Meguenani, M Miljkovic‐Licina, E Fagiani, P Ropraz, P Hammel, ... The FASEB Journal 29 (8), 3411-3425, 2015 | 14 | 2015 |
| Melanoma: targeting signaling pathways and RaLP L Pasini, MY Turco, L Luzi, E Aladowicz, E Fagiani, L Lanfrancone Expert Opinion on Therapeutic Targets 13 (1), 93-104, 2009 | 14 | 2009 |
| A Pygopus 2-Histone interaction is critical for cancer cell dedifferentiation and progression in malignant breast cancer M Saxena, RKR Kalathur, N Rubinstein, A Vettiger, N Sugiyama, ... Cancer research 80 (17), 3631-3648, 2020 | 13 | 2020 |
| VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue E Fagiani, P Lorentz, R Bill, K Pavotbawan, L Kopfstein, G Christofori Angiogenesis 19, 339-358, 2016 | 13 | 2016 |
| An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models E Fagiani, R Bill, L Pisarsky, R Ivanek, C Rüegg, G Christofori Angiogenesis 18, 327-345, 2015 | 11 | 2015 |
| VEGF-E 通过 VEGF 受体 2 特异性调控诱导正常和恶性组织中血管瘤样病变发生 E Fagiani 中国口腔颌面外科杂志, 2016 | | 2016 |
| A glycolytic switch overcomes anti-angiogenic cancer therapy R Bill, L Pisarsky, E Fagiani, R Ivanek, G Christofori ANGIOGENESIS 17 (3), 721-722, 2014 | | 2014 |
| Italian contribution to research AM Gruszka, C Martinelli, E Sparacio, PG Pelicci, A de Marco, MT Voso, ... | | 2011 |
| Tumor angiogenesis, lymphangiogenesis, and cell plasticity A Zumsteg, V Baeriswyl, I Albrecht, E Fagiani, T Schomber, G Christofori JOURNAL OF VASCULAR RESEARCH 46, 28-28, 2009 | | 2009 |
| Is RaLP, a new member of the Shc family, a critical determinant in the melanoma metastatic process? E Aladowicz, G Giardina, S Cristina, M Quarto, M Capra, M Giovanni, ... Cancer Research 68 (9_Supplement), 1983-1983, 2008 | | 2008 |
| RaLP adaptor protein modulates stem cell migration and differentiation MY Turco, G Giardina, E Aladowicz, A Pianaroli, B Ortensi, G Pelicci, ... PIGMENT CELL & MELANOMA RESEARCH 21 (2), 308-309, 2008 | | 2008 |
| A new member of the Shc family, RaLP, is involved in the melanoma apoptotic pathways E Fagiani, G Giardina, C Spinelli, E Aladowicz, G Mazzarol, A Testori, ... Melanoma Research 16, S65, 2006 | | 2006 |
